Dpy19l1 knockdown does not affect neuronal differentiation. E14.5 mouse embryos were electroporated with control (A-A″ ,E) or Dpy19l1 shRNA (sh1769, B-B″ ,F-H″ ) and analyzed at E16.5 (A-B″ ) or P2 (E-H″ ). (A-B″ ) BrdU incorporation in VZ cells at E16.5. (C) Quantification of BrdU-labeled cells. The percentage of GFP and BrdU double-positive cells in the basal region of the VZ (brackets in A′,B′) is plotted as the mean ± s.e.m. (three embryos each for control and sh1769). (D) Quantification of Cux1-positive cells. The percentage of GFP and Cux1 double-positive cells in the E17.5 CP-IZ is plotted as the mean ± s.e.m. (three embryos each for control and sh1769). (E-H″ ) Double immunostaining of GFP and Cux1 at P2. In control embryos, most GFP-positive cells were immunolabeled by Cux1. In Dpy19l1-downregulated brains, Cux1 was expressed in GFP-positive cells that had stalled abnormally in the IZ and the CP, as well as in neurons that were correctly positioned in the upper cortex. Boxed areas in F are magnified in G-H″ . Scale bars: 20 μm in A-B″ ,G-H″ ; 100 μm in E,F.